Sunzen Biotech Bhd Total Liabilities

Latest as of March 2024: RM18.73 Million MYR ≈ $4.70 Million USD

Sunzen Biotech Bhd total liabilities. Based on the latest financial reports, Sunzen Biotech Bhd (0148) has total liabilities worth RM18.73 Million MYR (≈ $4.70 Million USD) as of March 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sunzen Biotech Bhd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Sunzen Biotech Bhd (2016–2023)

Total liabilities of Sunzen Biotech Bhd from 2016 to 2023. This chart illustrates how Sunzen Biotech Bhd's total liabilities have evolved over time, based on quarterly financial data.

Sunzen Biotech Bhd Competitors by Total Liabilities

The table below lists competitors of Sunzen Biotech Bhd ranked by their total liabilities.

Company	Country	Total Liabilities
Fractal Gaming Group AB ST:FRACTL	Sweden	Skr190.80 Million
JC Chemical Co. Ltd KQ:137950	Korea	₩265.18 Billion
K Seng Seng Corporation Bhd KLSE:5192	Malaysia	RM160.49 Million
Kentucky First Federal Bancorp NASDAQ:KFFB	USA	$312.10 Million
Joinsoon Electronics MFG Co Ltd TWO:3322	Taiwan	NT$2.03 Billion
Abcourt Mines Inc. V:ABI	Canada	CA$60.16 Million
PBG S.A SA:PTBL3	Brazil	R$3.37 Billion
Krynica Vitamin SA WAR:KVT	Poland	zł104.22 Million

Liability Composition Analysis (2016–2023)

This chart breaks down Sunzen Biotech Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sunzen Biotech Bhd (0148) total assets.

Liquidity & Leverage Metrics

Sunzen Biotech Bhd Total Liabilities Ratios Explained

Sunzen Biotech Bhd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sunzen Biotech Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sunzen Biotech Bhd (2016–2023)

The table below shows the annual total liabilities of Sunzen Biotech Bhd from 2016 to 2023.

Year	Total Liabilities	Change
2023-12-31	RM20.51 Million ≈ $5.15 Million	-29.46%
2022-12-31	RM29.08 Million ≈ $7.30 Million	-5.01%
2021-12-31	RM30.61 Million ≈ $7.69 Million	-14.34%
2020-12-31	RM35.73 Million ≈ $8.97 Million	-3.32%
2019-12-31	RM36.96 Million ≈ $9.28 Million	-9.05%
2018-12-31	RM40.63 Million ≈ $10.20 Million	+106.30%
2017-12-31	RM19.70 Million ≈ $4.95 Million	+119.33%
2016-12-31	RM8.98 Million ≈ $2.25 Million	--

About Sunzen Biotech Bhd

KLSE:0148 Malaysia Packaged Foods

Market Cap

$43.17 Million

RM171.96 Million MYR

Market Cap Rank

#22258 Global

#504 in Malaysia

Share Price

RM0.22

Change (1 day)

+0.00%

52-Week Range

RM0.22 - RM0.29

All Time High

RM0.44